Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Liminal Biosciences Inc (LMNL)

Liminal Biosciences Inc (LMNL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Liminal Biosciences Inc 440 Armand-Frappier Boulevard Suite 300 Laval A8 H7V 4B4 CAN

www.liminalbiosciences.com P: 450-781-0115

Description:

Liminal BioSciences Inc. is a biotechnology company. It engages in discovering, developing and commercializing novel small molecule compounds for respiratory, liver and renal diseases. The company's product pipeline consists of PBI-4050, which are in clinical stage. Liminal BioSciences Inc., formerly known as Prometic Life Sciences Inc., is based in Laval, Canada.

Key Statistics

Overview:

Market Capitalization, $K 26,386
Enterprise Value, $K -2,184
Shares Outstanding, K 3,104
Annual Sales, $ 310 K
Annual Net Income, $ 380 K
Last Quarter Sales, $ 80 K
Last Quarter Net Income, $ -6,800 K
EBIT, $ -23,580 K
EBITDA, $ -22,720 K
60-Month Beta 1.03
% of Insider Shareholders 2.20%
% of Institutional Shareholders 0.66%
Float, K 3,036
% Float 97.80%
Short Volume Ratio 0.75

Growth:

1-Year Return 88.89%
3-Year Return -92.29%
5-Year Return -99.80%
5-Year Revenue Growth -98.97%
5-Year Earnings Growth 99.40%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.15 on 08/08/23
Latest Earnings Date 11/08/23
Earnings Per Share ttm -6.76
EPS Growth vs. Prev Qtr -18.78%
EPS Growth vs. Prev Year -34.38%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 02/01/23

LMNL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -88.44%
Return-on-Assets % -64.15%
Profit Margin % 122.58%
Debt/Equity 0.02
Price/Sales 85.57
Price/Cash Flow N/A
Price/Book 1.65
Book Value/Share 5.15
Interest Coverage -26.29
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar